Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 9;13(5):e14928.
doi: 10.7759/cureus.14928.

Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient

Dhigishaba M Jadeja  1 , Nirmit R Patel  2
Affiliations
Case Reports

Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient

Dhigishaba M Jadeja et al. Cureus. .

Abstract

Severe acute respiratory syndrome coronavirus 2 has had an indelible effect, with 153,738,171 cases recorded globally as per the World Health Organization's dashboard. The medical establishment is racing to find repurposed medications that can be successful against this novel coronavirus due to a shortage of new drugs to treat the disease. Favipiravir, an antiviral drug originally developed for influenza, is one of the drugs that has recently received a lot of attention, particularly in India. Here, we present a case of favipiravir-induced drug fever in a young adult coronavirus disease 2019 patient.

Keywords: covid-19; favipiravir; fever.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Timeline of favipiravir administration and body temperature.
Scattered line represents the clinical illness on the day of favipiravir administration.
See this image and copyright information in PMC

Similar articles

  • Favipiravir: A new and emerging antiviral option in COVID-19.
    Agrawal U, Raju R, Udwadia ZF. Agrawal U, et al. Med J Armed Forces India. 2020 Oct;76(4):370-376. doi: 10.1016/j.mjafi.2020.08.004. Epub 2020 Sep 2. Med J Armed Forces India. 2020. PMID: 32895599 Free PMC article. Review.
  • Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19).
    McCullough PA. McCullough PA. Antimicrob Agents Chemother. 2020 Nov 17;64(12):e02017-20. doi: 10.1128/AAC.02017-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32967849 Free PMC article.
  • Favipiravir, an anti-influenza drug against life-threatening RNA virus infections.
    Shiraki K, Daikoku T. Shiraki K, et al. Pharmacol Ther. 2020 May;209:107512. doi: 10.1016/j.pharmthera.2020.107512. Epub 2020 Feb 22. Pharmacol Ther. 2020. PMID: 32097670 Free PMC article. Review.
  • Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna, Kighoma PM, Koundouno FR, Réné Lolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fiz… See abstract for full author list ➔ Sissoko D, et al. PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar. PLoS Med. 2016. PMID: 26930627 Free PMC article. Clinical Trial.
  • Uric Acid Elevation by Favipiravir, an Antiviral Drug.
    Mishima E, Anzai N, Miyazaki M, Abe T. Mishima E, et al. Tohoku J Exp Med. 2020 Jun;251(2):87-90. doi: 10.1620/tjem.251.87. Tohoku J Exp Med. 2020. PMID: 32536670 Review.
See all similar articles

References

    1. Prevalence and cross states comparison of case fatality rate and recovery rate of COVID 19/SARS-COV-2 in India. Ansari AZ, Desai HD, Sharma K, Jadeja DM, Patel R, Patel Y, Desai HM. J Family Med Prim Care. 2021;10:475–480. - PMC - PubMed
    1. COVID-19 pandemic induced stress cardiomyopathy: a literature review. Desai HD, Sharma K, Jadeja DM, Desai HM, Moliya P. Int J Cardiol Heart Vasc. 2020;31:100628. - PMC - PubMed
    1. Predictors of mortality amongst tocilizumab administered COVID-19 Asian Indians: a predictive study from a tertiary care centre. Desai HD, Sharma K, Parikh A, et al. Cureus. 2021;13:0. - PMC - PubMed
    1. Takotsubo syndrome a rare entity in patients with COVID-19: an updated review of case-reports and case-series. Desai HD, Jadeja DM, Sharma K. Int J Cardiol Heart Vasc. 2020;29:100604. - PMC - PubMed
    1. A case of hemolytic anemia with acute myocarditis and cardiogenic shock: a rare presentation of COVID-19. Singhavi R, Sharma K, Desai HD, Patel R, Jadeja D. Cureus. 2020;12:0. - PMC - PubMed

Publication types

LinkOut - more resources